Human Monoclonal Antibodies as Candidate Therapeutics Against Emerging Viruses and HIV-1

被引：0

作者：

Zhongyu Zhu ^{[1
]}

Ponraj Prabakaran ^{[1
,2
]}

Weizao Chen ^{[1
]}

Christopher CBroder ^{[3
]}

Rui Gong ^{[4
]}

Dimiter SDimitrov ^{[1
]}

机构：

[1] Protein Interactions Group, National Cancer Institute, National Institutes of Health

[2] Basic Research Program, Science Applications International Corporation-Frederick, Inc

[3] Department of Microbiology and Immunology, Uniformed Services University

[4] Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences

来源：

Virologica Sinica | 2013年 / 28卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

More than 40 monoclonal antibodies (mAbs) have been approved for a number of disease indications with only one of these (Synagis) - for a viral disease, and not for therapy but for prevention. However, in the last decade novel potent mAbs have been discovered and characterized with potential as therapeutics against viruses of major importance for public health and biosecurity including Hendra virus (HeV), Nipah virus (NiV), severe acute respiratory syndrome coronavirus (SARS-CoV), Ebola virus (EBOV), West Nile virus (WNV), influenza virus (IFV) and human immunodeficiency virus type 1 (HIV-1). Here, we review such mAbs with an emphasis on antibodies of human origin, and highlight recent results as well as technologies and mechanisms related to their potential as therapeutics.

引用

页码：71 / 80

页数：10

共 50 条

[41] Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci [J].

He, YX ;

Honnen, WJ ;

Krachmarov, CP ;

Burkhart, M ;

Kayman, SC ;

Corvalan, J ;

Pinter, A .

JOURNAL OF IMMUNOLOGY, 2002, 169 (01) :595-605

[42] Human Anti-V2 Monoclonal Antibodies Neutralize Tier 1 HIV-1 Pseudoviruses [J].

Gorny, M. K. ;

Williams, C. ;

O'Neal, T. ;

Wang, X. ;

Seaman, M. S. ;

Zolla-Pazner, S. .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) :A9-A9

[43] Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure [J].

Umotoy, Jeffrey C. ;

de Taeye, Steven W. .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[44] Human antibodies targeting ENPP1 as candidate therapeutics for cancers [J].

Chu, Xiaojie ;

Baek, Du-San ;

Li, Wei ;

Shyp, Taras ;

Mooney, Brian ;

Hines, Margaret G. ;

Morin, Gregg B. ;

Sorensen, Poul H. ;

Dimitrov, Dimiter S. .

FRONTIERS IN IMMUNOLOGY, 2023, 14

[45] Are Broadly Neutralizing Antibodies against HIV-1 Unusual? [J].

Scott, Jamie Kathleen ;

Wang, X. ;

Wu, S. ;

Lepik, C. ;

Singh, H. ;

Richman, D. D. ;

Utz, P. J. ;

Breden, F. .

JOURNAL OF IMMUNOLOGY, 2007, 178

[46] REPERTOIRE FREEZE OF ANTIBODIES AGAINST HIV-1 PROTEINS [J].

MULLER, S ;

WANG, HT ;

SILVERMAN, G ;

KOHLER, H .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06) :734-734

[47] Progress on the Induction of Neutralizing Antibodies Against HIV Type 1 (HIV-1) [J].

Vaine, Michael ;

Lu, Shan ;

Wang, Shixia .

BIODRUGS, 2009, 23 (03) :137-153

[48] Development of Monoclonal Antibodies against HIV-1 p24 Protein and Its Application in Colloidal Gold Immunochromatographic Assay for HIV-1 Detection [J].

Ma, Yi ;

Ni, Chao ;

Dzakah, Emmanuel E. ;

Wang, Haiying ;

Kang, Keren ;

Tang, Shixing ;

Wang, Jihua ;

Wang, Jufang .

BIOMED RESEARCH INTERNATIONAL, 2016, 2016

[49] IDENTIFICATION OF LARGE GLYCOSYLATED PROTEINS RECOGNIZED BY MONOCLONAL-ANTIBODIES AGAINST HIV-1 GAG PROTEINS [J].

PINTER, A ;

HONNEN, WJ ;

REVESZ, K ;

HERZ, R .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) :1341-1344

[50] Progress on the Induction of Neutralizing Antibodies Against HIV Type 1 (HIV-1) [J].

Michael Vaine ;

Shan Lu ;

Shixia Wang .

BioDrugs, 2009, 23 :137-153

← 1 2 3 4 5 →